Actinium Pharmaceuticals Inc (ATNM)
8.40
+0.62
(+7.97%)
USD |
NYAM |
May 02, 11:26
Actinium Pharmaceuticals Cash from Operations (Quarterly): -7.374M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -7.374M |
December 31, 2023 | -7.49M |
September 30, 2023 | -11.12M |
June 30, 2023 | -13.64M |
March 31, 2023 | -15.08M |
December 31, 2022 | -7.778M |
September 30, 2022 | -5.715M |
June 30, 2022 | 27.92M |
March 31, 2022 | -5.781M |
December 31, 2021 | -5.052M |
September 30, 2021 | -5.588M |
June 30, 2021 | -4.584M |
March 31, 2021 | -5.642M |
December 31, 2020 | -6.258M |
September 30, 2020 | -4.994M |
June 30, 2020 | -4.511M |
March 31, 2020 | -5.854M |
December 31, 2019 | -5.011M |
September 30, 2019 | -5.598M |
June 30, 2019 | -5.364M |
March 31, 2019 | -5.489M |
December 31, 2018 | -4.287M |
September 30, 2018 | -6.614M |
June 30, 2018 | -4.211M |
March 31, 2018 | -5.459M |
Date | Value |
---|---|
December 31, 2017 | -3.168M |
September 30, 2017 | -5.87M |
June 30, 2017 | -7.140M |
March 31, 2017 | -5.375M |
December 31, 2016 | -4.241M |
September 30, 2016 | -5.570M |
June 30, 2016 | -6.222M |
March 31, 2016 | -4.756M |
December 31, 2015 | -3.964M |
September 30, 2015 | -3.499M |
June 30, 2015 | -5.267M |
March 31, 2015 | -5.813M |
December 31, 2014 | -5.047M |
September 30, 2014 | -4.239M |
June 30, 2014 | -2.571M |
March 31, 2014 | -2.491M |
December 31, 2013 | -1.344M |
September 30, 2013 | -1.620M |
June 30, 2013 | -1.016M |
March 31, 2013 | -2.312M |
December 31, 2012 | -1.417M |
September 30, 2012 | -1.933M |
June 30, 2012 | -0.9143M |
March 31, 2012 | -0.9479M |
December 31, 2011 | -0.5225M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.08M
Minimum
Mar 2023
27.92M
Maximum
Jun 2022
-5.226M
Average
-5.678M
Median
Cash from Operations (Quarterly) Benchmarks
Perspective Therapeutics Inc | -9.008M |
Eli Lilly and Co | 1.166B |
Cellectar Biosciences Inc | -9.596M |
Outlook Therapeutics Inc | -13.03M |
Bristol-Myers Squibb Co | 2.834B |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.011M |
Cash from Financing (Quarterly) | 14.77M |
Free Cash Flow | -39.72M |
Free Cash Flow Per Share (Quarterly) | -0.2648 |
Free Cash Flow Yield | -17.42% |